Huminig, Hilardo B.

HRN: 29-02-82  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
CEFTRIAXONE 1G (VIAL)
05/21/2026
05/27/2026
IV
2g
Od
Lacerated Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: